These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 8151128

  • 1. High plasma level of a eumelanin precursor, 6-hydroxy-5-methoxyindole-2-carboxylic acid as a prognostic marker for malignant melanoma.
    Hara H, Walsh N, Yamada K, Jimbow K.
    J Invest Dermatol; 1994 Apr; 102(4):501-5. PubMed ID: 8151128
    [Abstract] [Full Text] [Related]

  • 2. Production, circulation, and excretion of melanin-related metabolites in B16 melanoma-bearing mice.
    Wakamatsu K, Ito S, Fujita K.
    Acta Derm Venereol; 1990 Apr; 70(5):367-72. PubMed ID: 1980967
    [Abstract] [Full Text] [Related]

  • 3. Measurement of eumelanin precursor metabolites in the urine as a new marker for melanoma metastases.
    Yamada K, Walsh N, Hara H, Jimbow K, Chen H, Ito S.
    Arch Dermatol; 1992 Apr; 128(4):491-4. PubMed ID: 1580656
    [Abstract] [Full Text] [Related]

  • 4. Determination of eumelanin in human urine.
    Wakamatsu K, Takasaki A, Kågedal B, Kageshita T, Ito S.
    Pigment Cell Res; 2006 Apr; 19(2):163-9. PubMed ID: 16524432
    [Abstract] [Full Text] [Related]

  • 5. Normal values of urinary excretion and serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid, biochemical markers of melanoma progression.
    Wakamatsu K, Ito S, Horikoshi T.
    Melanoma Res; 1991 Apr; 1(2):141-7. PubMed ID: 1823626
    [Abstract] [Full Text] [Related]

  • 6. S100B protein, 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid as biochemical markers for survival prognosis in patients with malignant melanoma.
    Kärnell R, von Schoultz E, Hansson LO, Nilsson B, Arstrand K, Kågedal B.
    Melanoma Res; 1997 Oct; 7(5):393-9. PubMed ID: 9429222
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of melanin-related metabolites as markers of melanoma progression.
    Horikoshi T, Ito S, Wakamatsu K, Onodera H, Eguchi H.
    Cancer; 1994 Feb 01; 73(3):629-36. PubMed ID: 8299084
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of melanin-related metabolites as markers of solar ultraviolet-B radiation.
    Wakamatsu K, Ito S.
    Pigment Cell Res; 2006 Oct 01; 19(5):460-4. PubMed ID: 16965276
    [Abstract] [Full Text] [Related]

  • 9. Eumelanin (precursor) metabolites as markers for pigmented malignant melanoma: a preliminary report.
    Pavel S, Muskiet FA.
    Cancer Detect Prev; 1983 Oct 01; 6(1-2):311-6. PubMed ID: 6883388
    [Abstract] [Full Text] [Related]

  • 10. Melanin-related metabolites in urine of B16 melanoma-bearing mice.
    Wakamatsu K, Ito S, Fujita K.
    Acta Derm Venereol; 1988 Oct 01; 68(5):385-9. PubMed ID: 2461020
    [Abstract] [Full Text] [Related]

  • 11. A method for measuring serum levels of melanin-associated indole metabolites using LC-MS/MS and its application to malignant melanoma.
    Takiwaki M, Umemura H, Kikutani Y, Fukuzawa S, Abe K, Fujino K, Sugihara S, Tachibana K, Morizane S, Satoh M, Nakayama T, Yamasaki O.
    Clin Chim Acta; 2024 Apr 15; 557():117873. PubMed ID: 38493943
    [Abstract] [Full Text] [Related]

  • 12. Seasonal variation in serum concentration of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in healthy Japanese.
    Wakamatsu K, Ito S.
    Pigment Cell Res; 1995 Jun 15; 8(3):132-4. PubMed ID: 7567788
    [Abstract] [Full Text] [Related]

  • 13. Correlation between urinary melanin-related metabolites and tumour weight in melanoma-bearing mice.
    Ito S, Wakamatsu K, Inoue S, Fujita K.
    Acta Derm Venereol; 1989 Jun 15; 69(5):380-4. PubMed ID: 2572100
    [Abstract] [Full Text] [Related]

  • 14. Comparison of phaeomelanin and its precursor 5-S-cysteinyldopa in the serum of melanoma patients.
    Wakamatsu K, Yokochi M, Naito A, Kageshita T, Ito S.
    Melanoma Res; 2003 Aug 15; 13(4):357-63. PubMed ID: 12883361
    [Abstract] [Full Text] [Related]

  • 15. [Eumelanin and pheomelanin contents in hairs of healthy Japanese and patients with oculocutaneous albinism, and 5-S-cysteinyldopa and 5-hydroxy-6-methoxyindole-2-carboxylic acid levels in urine of oculocutaneous albinism].
    Saito N, Morishima T.
    Nihon Hifuka Gakkai Zasshi; 1990 Jul 15; 100(8):853-61. PubMed ID: 2122048
    [Abstract] [Full Text] [Related]

  • 16. Urinary excretion of 5-S-cysteinyldopa and 6-hydroxy-5-methoxyindole-2-carboxylic acid in children.
    Meyerhöffer S, Lindberg Z, Häger A, Kågedal B, Rosdahl I.
    Acta Derm Venereol; 1998 Jan 15; 78(1):31-5. PubMed ID: 9498023
    [Abstract] [Full Text] [Related]

  • 17. Serum 5-S-cysteinyldopa (5-S-CD) as a marker of melanoma progression.
    Horikoshi T, Ito S.
    J Dermatol; 1992 Nov 15; 19(11):809-13. PubMed ID: 1293168
    [Abstract] [Full Text] [Related]

  • 18. Cysteine and indole derivatives as markers for malignant melanoma.
    Hartleb J, Arndt R.
    J Chromatogr B Biomed Sci Appl; 2001 Nov 25; 764(1-2):409-43. PubMed ID: 11817040
    [Abstract] [Full Text] [Related]

  • 19. Some indolic compounds as markers of the melanocyte activity.
    Hansson C.
    Acta Derm Venereol Suppl (Stockh); 1988 Nov 25; 138():1-60. PubMed ID: 3176811
    [Abstract] [Full Text] [Related]

  • 20. Insect cuticular melanins are distinctly different from those of mammalian epidermal melanins.
    Barek H, Sugumaran M, Ito S, Wakamatsu K.
    Pigment Cell Melanoma Res; 2018 May 25; 31(3):384-392. PubMed ID: 29160957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.